MoneyWorks4Me

Shree Ganesh Remed. - Quaterly Results

05 Feb 2025 Evaluate
The revenue slipped marginally during the December 2024 quarter. A decline of about Rs. 270.53 millions was observed as compared to Rs. 279.74 millions during the corresponding quarter last year.The Company has registered profit of Rs. 54.33  millions for the quarter ended December 2024, a growth of 13.19%  over Rs. 48.00 millions millions achieved in the corresponding quarter of last year.Operating Profit saw a handsome growth to 106.10 millions from 93.19 millions in the quarter ended December 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 270.53 279.74 -3.29 841.65 882.24 -4.60 1258.95 913.58 37.80
Other Income 7.10 11.12 -36.15 14.43 22.37 -35.49 30.67 7.17 327.75
PBIDT 106.10 93.19 13.85 307.77 265.81 15.79 448.77 241.60 85.75
Interest 3.75 0.18 1983.33 11.19 0.64 1648.44 5.98 1.80 232.22
PBDT 102.35 93.01 10.04 296.58 265.17 11.85 442.79 239.80 84.65
Depreciation 27.00 18.81 43.54 71.42 43.01 66.05 61.10 37.42 63.28
PBT 75.35 74.20 1.55 225.16 222.16 1.35 381.69 202.38 88.60
TAX 21.02 26.20 -19.77 60.15 63.21 -4.84 100.52 50.53 98.93
Deferred Tax 0.22 6.00 -96.33 0.36 6.89 -94.78 6.74 -2.84 -337.32
PAT 54.33 48.00 13.19 165.01 158.95 3.81 281.17 151.85 85.16
Equity 128.43 125.11 2.65 128.43 125.69 2.18 125.83 121.07 3.93
PBIDTM(%) 39.22 33.31 17.73 36.57 30.13 21.37 35.65 26.45 34.79
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..